$ 0 0 World Drug Tracker: LEVOSIMENDAN – Oxygen Biotherapeutics Selects Duke Clinical Research Institute to Conduct Phase 3 Trial of Levosimendan LEVOSIMENDANFiled under: Uncategorized Tagged: LEVOSIMENDAN